Sk Biopharmaceuticals Co Ltd (326030) — Net Asset Momentum
Sk Biopharmaceuticals Co Ltd (326030) recorded a net asset momentum of 44.0% as of December 2025, with net assets of ₩826.27 Billion KRW. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See defensive interval ratio of Sk Biopharmaceuticals Co Ltd to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Sk Biopharmaceuticals Co Ltd Net Asset Momentum (2016–2025)
This chart tracks Sk Biopharmaceuticals Co Ltd's year-over-year net asset growth across 10 annual reporting periods from 2016 to 2025. The most recent momentum reading is +44.0%, with net assets of ₩826.27 Billion KRW as of December 2025. Read debt load of Sk Biopharmaceuticals Co Ltd for a breakdown of total debt and financial obligations.
Annual Net Asset History for Sk Biopharmaceuticals Co Ltd (2016–2025)
The table below shows the complete annual net asset history for Sk Biopharmaceuticals Co Ltd from 2016 to 2025, covering 10 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Sk Biopharmaceuticals Co Ltd market capitalisation.
| Year | Net Assets (KRW) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | ₩826.27 Billion | ₩1.20 Trillion | ₩372.04 Billion | ▲ +44.0% |
| 2024 | ₩573.98 Billion | ₩1.04 Trillion | ₩462.83 Billion | ▲ +78.8% |
| 2023 | ₩320.95 Billion | ₩723.17 Billion | ₩402.22 Billion | ▲ +1.4% |
| 2022 | ₩316.56 Billion | ₩664.24 Billion | ₩347.68 Billion | ▼ -28.7% |
| 2021 | ₩444.19 Billion | ₩643.65 Billion | ₩199.46 Billion | ▲ +17.2% |
| 2020 | ₩379.07 Billion | ₩500.24 Billion | ₩121.17 Billion | ▲ +3010.2% |
| 2019 | ₩-13.03 Billion | ₩139.07 Billion | ₩152.10 Billion | ▼ -122.2% |
| 2018 | ₩58.63 Billion | ₩95.54 Billion | ₩36.91 Billion | ▲ +24.1% |
| 2017 | ₩47.24 Billion | ₩98.37 Billion | ₩51.12 Billion | ▼ -68.0% |
| 2016 | ₩147.69 Billion | ₩193.89 Billion | ₩46.21 Billion | — |